Silver Lining Textiles (SLT)Â launches UNDER SCRUB, a medical technical base layer that kills the bacteria that causes infection, with hopes of reducing transmission from patient to patient.
UNDER SCRUB announces its use of innovative yarn technology in the weaving of a protective base layer to help fight the spread of hospital-acquired infections. Products are available exclusively at the company's e-commerce site www.underscrub.com.
"We've done extensive research and development to create a product with superior efficacy against commonly occurring bacteria encountered in both hospitals and the community," says Jason Katsapetses, founder and CEO of SLT. "Independent test results consistently demonstrate rapid and massive reduction of bacteria within minutes of exposure to our highly technical fabric."
UNDER SCRUB is one of the first revolutionary base layers with antimicrobial, anti-fungal and anti-odor properties that are embedded "within the yarn," thus remaining effective for the life of the garment. This new yarn technology, using natural elements, is designed to deliver extreme permanent protection, unlike harsh chemical finishes that are applied topically.
Kevin Young, MD, SLT's medical director, notes, "We speculate that this innate antimicrobial ability could dramatically reduce the risk of nosocomial infection and microbial transmission both in the hospital and the community. This would reduce risk without any active participation by the healthcare provider wearing our technical fabrics. Unlike handwashing, this product does not require someone following protocol."
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.